Sponsor

University of Maryland, Baltimore

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Maryland, Baltimore appears in 265 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials265
Recruiting shown25
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma SuspectsNCT04401982 · lead sponsor · 2026-07-02
RECRUITING
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple SclerosisNCT06864936 · lead sponsor · 2026-05-01
RECRUITING
GCC 2546- Motion ManagementNCT07398209 · lead sponsor · 2026-04-14
RECRUITING
TMS for Inhibition Enhancement in SchizophreniaNCT06155682 · lead sponsor · 2026-02-02
RECRUITING
Improving Glycemic Control With Telemedicine and Smart Insulin PensNCT06918977 · lead sponsor · 2026-01-30
RECRUITING
Metabotyping of Broccoli Microgreen in Obese Breast Cancer SurvivorsNCT07032545 · lead sponsor · 2025-12-03
RECRUITING
Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin MicroscopyNCT06993597 · lead sponsor · 2025-09-01
RECRUITING
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung CancerNCT06800339 · lead sponsor · 2025-04-22
RECRUITING
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung CancerNCT07008664 · lead sponsor · 2025-03-31
RECRUITING
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)NCT06501781 · lead sponsor · 2025-03-18
RECRUITING
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIVNCT06624839 · lead sponsor · 2025-03-15
RECRUITING
White Matter Plasticity in SchizophreniaNCT06641297 · lead sponsor · 2025-01-02
RECRUITING
Induction of Labor in Morbidly Obese PatientsNCT06199154 · lead sponsor · 2024-07-15
RECRUITING
Effect of Zinc on Glucose HomeostasisNCT05835037 · lead sponsor · 2024-02-16
RECRUITING
Ocular Blood Flow Imaging for Glaucoma AssessmentNCT05726058 · lead sponsor · 2023-03-30
RECRUITING
Targeting Emotion Dysregulation to Reduce Suicide in People With PsychosisNCT05440214 · lead sponsor · 2022-12-02
RECRUITING
TERPS Trial for de Novo Oligometastic Prostate CancerNCT05223803 · lead sponsor · 2022-10-18
RECRUITING
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung CancerNCT05450965 · lead sponsor · 2022-07-19
RECRUITING
Retinal Blood Flow and AutoregulationNCT05344274 · lead sponsor · 2022-05-23
RECRUITING
Pharmacogenetics of Response to GLP1R AgonistsNCT05071898 · lead sponsor · 2022-04-11
RECRUITING
Glucose Variability and Cognition in PrediabetesNCT04201600 · lead sponsor · 2022-03-01
RECRUITING
GammaPod Dose Escalation Radiation for Early Stage Breast CancerNCT04234386 · lead sponsor · 2021-09-15
RECRUITING
GammaPod Registry and Quality of Life NomogramNCT03562273 · lead sponsor · 2019-01-03
RECRUITING
Vasopressin and Pain Perception in the BrainNCT03446456 · lead sponsor · 2018-09-17
RECRUITING
The Effects of Fluoxetine and/or DHEANCT03228732 · lead sponsor · 2017-12-19
RECRUITING
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset PsychosisNCT03883360 · lead sponsor · 2050-01-01
WITHDRAWN
On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer RecoveryNCT06894563 · lead sponsor · 2027-06-01
NOT_YET_RECRUITING
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCNCT05403723 · lead sponsor · 2027-01-30
SUSPENDED
Pharmacogenetics of Response to Sitagliptin (PRS)NCT06813014 · lead sponsor · 2026-12-01
NOT_YET_RECRUITING
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast CancerNCT07374796 · lead sponsor · 2026-12-01
NOT_YET_RECRUITING
Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With SchizophreniaNCT07615075 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
OER Glibenclamide for Neuropathic Pain in Multiple SclerosisNCT07221799 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE TrialNCT07746388 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the LungNCT07679607 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Ginkgo Active App-Based Exercise TrainingNCT07411339 · lead sponsor · 2026-07-01
WITHDRAWN
Continuous Glucose Monitors (CGMs) and Readmission RatesNCT07221812 · lead sponsor · 2026-06-18
NOT_YET_RECRUITING
Resilient HIV Implementation Science With SGM Youths Using EvidenceNCT06350682 · lead sponsor · 2026-03-04
ENROLLING_BY_INVITATION
Client-Centered Care Coordination for Black Men Who Have Sex With MenNCT06056544 · lead sponsor · 2025-12-21
ENROLLING_BY_INVITATION
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIVNCT06691243 · lead sponsor · 2025-08-07
ACTIVE_NOT_RECRUITING
Brain Biomarker on Inflammation ResponseNCT03271814 · lead sponsor · 2025-01-01
WITHDRAWN
CGM/Clarity Use, Glycemic Control and Clinical OutcomesNCT03827434 · lead sponsor · 2024-11-22
WITHDRAWN
Enhancing Care & Outcomes for Patients During the First Postpartum YearNCT06615076 · lead sponsor · 2024-11-12
ACTIVE_NOT_RECRUITING
Behavioral Activation, Nutrition, and Activity InterventionNCT06239961 · lead sponsor · 2024-09-23
COMPLETED
Macitentan to Prevent PRVONCT05946811 · lead sponsor · 2024-05-01
WITHDRAWN
High-Risk Metachronous Oligometastatic Prostate Cancer TrialNCT06212583 · lead sponsor · 2024-04-17
ACTIVE_NOT_RECRUITING
UM CRMC RecuR Score PilotNCT05765903 · lead sponsor · 2024-03-31
WITHDRAWN
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessNCT05968144 · lead sponsor · 2024-01-29
ACTIVE_NOT_RECRUITING
The ROle of Compression StocKings in Heart Failure PatientsNCT06350695 · lead sponsor · 2024-01-17
UNKNOWN
Physical Acvitiy in PregnancyNCT07356180 · lead sponsor · 2023-10-18
ENROLLING_BY_INVITATION
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based InterventionNCT06002685 · lead sponsor · 2023-10-09
ACTIVE_NOT_RECRUITING
Ketogenic Diet in People With SchizophreniaNCT05968638 · lead sponsor · 2023-09-01
ACTIVE_NOT_RECRUITING
Re-engagement at Discharge 2NCT05694546 · lead sponsor · 2023-08-18
COMPLETED
Botswana Smoking and Abstinence Reinforcement TrialNCT05694637 · lead sponsor · 2023-07-25
ENROLLING_BY_INVITATION
Diabetes Prevention and EducationNCT05769127 · lead sponsor · 2023-04-26
WITHDRAWN
Prebiotic Treatment in People With SchizophreniaNCT05527210 · lead sponsor · 2023-01-25
ACTIVE_NOT_RECRUITING
TMS Related Biomarker AssessmentsNCT05660018 · lead sponsor · 2023-01-07
COMPLETED
Palliative Care for Persons With ADRD and CI in SNFNCT05308004 · lead sponsor · 2022-06-15
COMPLETED
Luteolin for the Treatment of People With SchizophreniaNCT05204407 · lead sponsor · 2022-06-13
COMPLETED
Risk Factors, Costs, and Impacts of ED BoardingNCT07532564 · lead sponsor · 2022-01-01
COMPLETED
Improving Glycemic Control in DM2 Patients in the Ambulatory SettingNCT04800471 · lead sponsor · 2021-08-16
COMPLETED

Drugs studied in this sponsor's trials

70 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Maryland, Baltimore as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo31
oxytocin5
galantamine4
varenicline4
cisplatin3
anastrozole2
atomoxetine2
canagliflozin2
placebo RxCUI 8375 · Lead sponsor in 29 linked trial(s) · 2 currently recruiting 31 trials oxytocin RxCUI 7824 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 5 trials galantamine RxCUI 4637 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials varenicline RxCUI 591622 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials cisplatin RxCUI 2555 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials anastrozole RxCUI 84857 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials atomoxetine RxCUI 38400 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials canagliflozin RxCUI 1373458 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials carboplatin RxCUI 40048 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials fluoxetine RxCUI 4493 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials lapatinib RxCUI 480167 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials letrozole RxCUI 72965 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials minocycline RxCUI 6980 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials misoprostol RxCUI 42331 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials paclitaxel RxCUI 56946 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials placebo Oral Tablet RxCUI 375221 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials prasterone RxCUI 3143 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials tryptophan RxCUI 10898 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials acamprosate RxCUI 82819 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial acetylcysteine RxCUI 197 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial adalimumab RxCUI 327361 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial alprazolam RxCUI 596 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial aripiprazole RxCUI 89013 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial atenolol RxCUI 1202 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor239
collaborator26
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.